StockData
Immatics N.V. logo

Immatics N.V. (IMTX) KPIs and segments

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.39−0.13 (-1.99%)

Close on Nov 13, 2026Market cap $856.72MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Immatics's business

Coming soon

This tab will track the numbers specific to Immatics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?